glp 1 drugs and pcos Ozempic (Semaglutide) for PMOS/PCOS: Pelvic Health Guide Everything You Wanted To Know

No reduction in food-related thoughts is guaranteed for any individual patient

This guide covers: How both medications work (same class, different molecules) Weight loss effectiveness: what the research shows Dosing schedules and administration differences Side effect comparison Cardiovascular and metabolic benefits Cost and insurance considerations Who might still consider Saxenda Making the transition from Saxenda to semaglutide Key Takeaways Both are GLP-1 receptor agonists working through the same fundamental mechanism to reduce appetite and enhance satiety Semaglutide produces roughly twice the weight loss (15% average) compared to liraglutide (5-8% average) Dosing convenience favors semaglutide: Weekly injection versus daily injection with Saxenda Side effects are similar since both work through GLP-1 pathways (primarily gastrointestinal) Saxenda is FDA-approved for weight loss

Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling

This aligns with the objective BrAC measurements, demonstrating consistency between subjective experiences and physiological effects

Pricing and reimbursement debates with payers